Octreotide News
Carcinoid syndrome
Surgery with complete removal of the tumor tissue is usually the first line treatment. It can result in permanent cure if it is possible to remove the tumor entirely.
New Disorder That Causes Chronic Diarrhea In Children Discovered By UCLA Researchers
UCLA researchers have unraveled a mysterious condition that causes congenital diarrhea and intestinal failure in children which may help further stem cell research for type I diabetes and intestinal disorders.
Acromegaly linked to growth hormone
Condition, which plagued wrestler Andre the Giant, has multiple symptoms and complications.
Octreotide May Be Effective in Treatment of Nonconstipated IBS
Octreotide reduces abdominal complaints and improves stool consistency, suggesting that it may be beneficial in nonconstipated irritable bowel syndrome (IBS), according to findings presented here at Digestive Disease Week 2005.
Sandostatin® LAR® approved in Japan for acromegaly and symptoms of gastrointestinal hormone secreting tumors
Novartis announced today that the Japanese health authority has approved Sandostatin® LAR® (octreotide acetate for injectable suspension) for the treatment of acromegaly and pituitary gigantism which is unresponsive to or...